| JXSB2300033 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.4) | Supplementary Application | 2023-03-28 | | Cilag AG;Janssen Research & Development LLC | | | view |
| JXSS2200013 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-04-15 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JXSS2500061 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-14 | | Johnson & Johnson;Cilag AG;Janssen-Cilag International NV | | | view |
| JXSL2300040 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-02-23 | | Janssen-Cilag International NV;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSL2200010 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.4) | Import Drug Application | 2022-01-19 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2500075 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2200040 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2022-03-10 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JXSS2000050 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-06 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV | Certificate Issued | 2021-10-11 | view |
| JYSB2300140 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2023-08-18 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2300204 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2023-12-08 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2500022 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2025-02-07 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2200015 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2022-01-30 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSZ2300047 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | License Renew | 2023-10-31 | | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2200528 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2000066 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-02-29 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-03-05 | view |
| JYSB2500003 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2300110 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-09 | | Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd | | | view |
| JYSB2000518 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-10-16 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-11-23 | view |
| JYSB2300079 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2101129 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2021-09-13 | | Cilag AG;Janssen-Cilag International NV | | | view |
